Get an overview of Novozymes' share price development and analyze the performance, or read about Novozymes' ownership structure.
The A common stock is held by Novo A/S, which is wholly owned by the Novo Nordisk Foundation. In addition, Novo A/S holds 29,131,400 B shares (11%). Altogether this gives Novo A/S 25.5% of the total common stock and 70.1% of the votes.
Read more about Novozymes' ownership structure here.